US OptionsDetailed Quotes
OLMA241220C10000
- 1.00
- 0.000.00%
15min DelayClose Nov 29 13:00 ET
0.00High0.00Low
1.00Open1.00Pre Close0 Volume2 Open Interest10.00Strike Price0.00Turnover103.09%IV8.70%PremiumDec 20, 2024Expiry Date0.12Intrinsic Value100Multiplier18DDays to Expiry0.88Extrinsic Value100Contract SizeAmericanOptions Type0.5702Delta0.1674Gamma10.12Leverage Ratio-0.0259Theta0.0024Rho5.77Eff Leverage0.0089Vega
Olema Pharmaceuticals Stock Discussion
Sign in to post a comment
$Olema Pharmaceuticals (OLMA.US)$ Olema Oncology to Present New Data Combining Palazestrant With Ribociclib at the San Antonio Breast Cancer Symposium
Olema will host an investor conference call at 8:00 a.m. ET on December 10, 2024
Poster Details
Title:A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib, in patients with estrogen receptor-positive, human epidermal gr...
Olema will host an investor conference call at 8:00 a.m. ET on December 10, 2024
Poster Details
Title:A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib, in patients with estrogen receptor-positive, human epidermal gr...
1
13
Although the sale doesn't necessarily signify a negative view on the company's future, absence of insider buying could induce concerns. Other company risks should be considered when investing.
Mr. Garland's expertise in biopharma is predicted to boost late-stage development of Olema's lead product. This could solidify the company's influence in shaping next-gen therapies for women's cancers.
1
$Olema Pharmaceuticals (OLMA.US)$ Olema Pharmaceuticals Announced New Preclinical Data Regarding The Discovery Of Novel Compounds Targeting KAT6, An Epigenetic Target That Is Dysregulated In Breast And Other Cancers
2
Gainers:
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
11
3
5
CAN I AT LEAST LEAST LEATHER HOW TO BUY N SELL STOCKS ON THIS BROCHURE MOOMOO 
FOR REAL I DONT GET IT 
Gainers:
In reaction to earnings/guidance:
• $Super Micro Computer (SMCI.US)$ +18%, $Nokia Oyj (NOK.US)$ +7.7%, $Danaher (DHR.US)$ +6.3%, $RLI Corp (RLI.US)$ +5%, $CSX Corp (CSX.US)$ +4.3%, $Las Vegas Sands (LVS.US)$ +4.2%, $Alcoa (AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics (STLD.US)$ +2.8%, $Herc Holdings (HRI.US)$ +2.6%, $Tesla (TSLA.US)$ +2.5%, $Philip Morris International (PM.US)$ +2.5%, $F.N.B. Corp (FNB.US)$ ...
In reaction to earnings/guidance:
• $Super Micro Computer (SMCI.US)$ +18%, $Nokia Oyj (NOK.US)$ +7.7%, $Danaher (DHR.US)$ +6.3%, $RLI Corp (RLI.US)$ +5%, $CSX Corp (CSX.US)$ +4.3%, $Las Vegas Sands (LVS.US)$ +4.2%, $Alcoa (AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics (STLD.US)$ +2.8%, $Herc Holdings (HRI.US)$ +2.6%, $Tesla (TSLA.US)$ +2.5%, $Philip Morris International (PM.US)$ +2.5%, $F.N.B. Corp (FNB.US)$ ...
11
6
Gainers:
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
21
3
$Olema Pharmaceuticals (OLMA.US)$ its in the gap up.!
4
1
No comment yet
MARKET-TEST-DUMMY :
joeyboulevard : what might it test?
Trytosaveabit OP joeyboulevard : Test? Sorry when it comes to me giving any type of answer. The question needs to be much more clear/direct! Hehehe! To many ways my simple mind can go with this. Hehehe. Hope you’re having a good weekend!
Trytosaveabit OP MARKET-TEST-DUMMY : Good stuff! Hehehe. Hope you’re having a great weekend. BTW with the wind today so far it feels like it’s about 19’ Hehehe. And I bet you’re working outside in a T! Hehehe
joeyboulevard Trytosaveabit OP : what price might you see it dropping to before entry on Monday?
View more comments...